PAM recognition by miniature CRISPR-Cas14 triggers programmable double-stranded DNA cleavage
Tautvydas Karvelis,Greta Bigelyte,Joshua K. Young,Zhenglin Hou,Rimante Zedaveinyte,Karolina Pociute,Arunas Silanskas,Česlovas Venclovas,Virginijus Siksnys +8 more
Reads0
Chats0
TLDR
It is demonstrated that a T-rich PAM sequence triggers Cas14 proteins to also cut double-stranded DNA generating staggered ends, paving the way for genome editing applications with Cas14s.Abstract:
Small and robust CRISPR-Cas nucleases are highly desirable for genome editing applications. Being guided by a RNA to cleave targets near a short sequence termed a protospacer adjacent motif (PAM), Cas9 and Cas12 offer unprecedented flexibility, however, smaller more compact versions would simplify delivery and extend application. Recently, a new class 2 system encoding a miniature (529 amino acids) effector, Cas14a1, has been shown to exclusively function as a PAM-independent single stranded DNA nuclease. Using biochemical methods, we show that a T-rich PAM sequence triggers Cas14 proteins to also cut double-stranded DNA generating staggered ends. Finally, we demonstrate the ability of Cas14a1 to target and cleave cellular human chromosomal DNA paving the way for genome editing applications with Cas14s.read more
Citations
More filters
Journal ArticleDOI
Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants.
Kira S. Makarova,Yuri I. Wolf,Jaime Iranzo,Sergey Shmakov,Omer S. Alkhnbashi,Stan J. J. Brouns,Emmanuelle Charpentier,David R. Cheng,Daniel H. Haft,Philippe Horvath,Sylvain Moineau,Francisco J. M. Mojica,David Scott,Shiraz A. Shah,Virginijus Siksnys,Michael P. Terns,Česlovas Venclovas,Malcolm F. White,Alexander F. Yakunin,Alexander F. Yakunin,Winston X. Yan,Feng Zhang,Roger A. Garrett,Rolf Backofen,John van der Oost,Rodolphe Barrangou,Eugene V. Koonin +26 more
TL;DR: An updated evolutionary classification of CRISPR–Cas systems and cas genes is provided, with an emphasis on the major developments that have occurred since the publication of the latest classification, in 2015, which includes 2 classes, 6 types and 33 subtypes.
Journal ArticleDOI
Recent advances in the CRISPR genome editing tool set.
TL;DR: Further improving the system’s DNA modification efficiency and the delivery of its components into cells, and finding ways to reduce off-target effects, will be required for CRISPR to realize its therapeutic potential.
Journal ArticleDOI
Genome Editing in Plants: Exploration of Technological Advancements and Challenges
Sanskriti Vats,Surbhi Kumawat,Virender Kumar,Gunvant Patil,Trupti Joshi,Humira Sonah,Tilak Raj Sharma,Rupesh Deshmukh +7 more
TL;DR: In the present review, several CRISPR/Cas based approaches have been discussed, considering recent advances and challenges to implicate those in the crop improvement programs, and a catalog of available computational tools and servers facilitating designing of guide-RNA targets, construct designs, and data analysis is provided.
Journal ArticleDOI
Applications of CRISPR-Cas systems in lactic acid bacteria
Avery Roberts,Rodolphe Barrangou +1 more
TL;DR: CRISPR-Cas classification, overview CRISPR biology and mechanism of action, and current and future applications in lactic acid bacteria are discussed, opening new avenues for their industrial exploitation and manipulation of microbiomes.
Journal ArticleDOI
CRISPR/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing.
TL;DR: The basic mechanisms underlying CRISPR/Cas9 working principles are explored along with some of its current applications in a number of diverse fields.
References
More filters
Journal ArticleDOI
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek,Krzysztof Chylinski,Krzysztof Chylinski,Ines Fonfara,Michael H. Hauer,Jennifer A. Doudna,Emmanuelle Charpentier +6 more
TL;DR: This study reveals a family of endonucleases that use dual-RNAs for site-specific DNA cleavage and highlights the potential to exploit the system for RNA-programmable genome editing.
Journal ArticleDOI
Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.
Bernd Zetsche,Jonathan S. Gootenberg,Omar O. Abudayyeh,Ian Slaymaker,Kira S. Makarova,Patrick Essletzbichler,Sara E. Volz,Julia Joung,John van der Oost,Aviv Regev,Aviv Regev,Eugene V. Koonin,Feng Zhang +12 more
TL;DR: In this paper, the authors characterized Cpf1, a putative class 2 CRISPR effector, which is a single RNA-guided endonuclease lacking tracrRNA and utilizes a T-rich protospacer-adjacent motif.
Journal ArticleDOI
Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
TL;DR: It is demonstrated that the Cas9–crRNA complex of the Streptococcus thermophilus CRISPR3/Cas system introduces in vitro a double-strand break at a specific site in DNA containing a sequence complementary to crRNA, paving the way for engineering of universal programmable RNA-guided DNA endonucleases.
Journal ArticleDOI
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Janice S. Chen,Enbo Ma,Lucas B. Harrington,Maria Da Costa,Xinran Tian,Joel M. Palefsky,Jennifer A. Doudna +6 more
TL;DR: It is shown that RNA-guided DNA binding unleashes indiscriminate single-stranded DNA cleavage activity by Cas12a that completely degrades ssDNA molecules, which is also a property of other type V CRISPR-Cas12 enzymes.
Journal ArticleDOI
Nucleic acid detection with CRISPR-Cas13a/C2c2
Jonathan S. Gootenberg,Omar O. Abudayyeh,Jeong Wook Lee,Patrick Essletzbichler,Aaron J. Dy,Aaron J. Dy,Julia Joung,Vanessa Verdine,Nina M. Donghia,Nichole M. Daringer,Catherine A. Freije,Catherine A. Freije,Cameron Myhrvold,Cameron Myhrvold,Roby P. Bhattacharyya,Jonathan Livny,Aviv Regev,Aviv Regev,Eugene V. Koonin,Deborah T. Hung,Pardis C. Sabeti,James J. Collins,Feng Zhang +22 more
TL;DR: A Cas13a-based molecular detection platform, termed Specific High-Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK), is used to detect specific strains of Zika and Dengue virus, distinguish pathogenic bacteria, genotype human DNA, and identify mutations in cell-free tumor DNA.